Cigna (CI) Financials: History & Chart

Cigna Corporation (CI)CICigna Corporation

About Cigna Corporation

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

Bloomfield, CT

67,700 employees

www.thecignagroup.com

Healthcare / Medical - Healthcare Plans

Sector: Healthcare
Industry: Medical - Healthcare Plans
CEO: Brian C. Evanko

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	277.94B	68.49B	72.47B	69.75B	67.23B	65.50B	65.65B	63.69B	60.52B
Cost of Goods Sold	252.09B	62.02B	66.92B	63.81B	59.34B	58.90B	59.19B	57.09B	54.01B
Gross Profit	25.85B	6.47B	5.55B	5.94B	7.89B	6.61B	6.46B	6.60B	6.52B
Gross Profit Margin	9.3%	9.4%	7.7%	8.5%	11.7%	10.1%	9.8%	10.4%	10.8%
Total Operating Expenses	16.33B	4.11B	3.41B	3.36B	5.45B	4.63B	4.29B	4.03B	4.10B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	13.92B	3.72B	3.41B	3.36B	3.43B	3.80B	3.74B	3.52B	3.63B
Operating Income (EBIT)	9.52B	2.36B	2.15B	2.58B	2.43B	1.97B	2.17B	2.58B	2.41B
Operating Margin	3.4%	3.4%	3.0%	3.7%	3.6%	3.0%	3.3%	4.0%	4.0%
Income Before Tax (EBT)	8.21B	2.27B	1.63B	2.29B	2.02B	1.65B	2.01B	1.19B	1.99B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	1.38B	357.00M	335.00M	347.00M	337.00M	362.00M	362.00M	376.00M	375.00M
Other Income/Expense	-1.30B	-88.00M	-519.00M	-283.00M	-411.00M	-323.00M	-164.00M	-1.38B	-423.00M
Net Income	6.29B	1.65B	1.23B	1.87B	1.53B	1.32B	1.42B	739.00M	1.55B
Income Tax Expense	1.51B	409.00M	395.00M	322.00M	389.00M	239.00M	473.00M	367.00M	360.00M
Net Profit Margin	2.3%	2.4%	1.7%	2.7%	2.3%	2.0%	2.2%	1.2%	2.6%
EBITDA	12.13B	3.01B	2.73B	3.27B	3.11B	2.65B	2.82B	3.23B	3.15B
EBITDA Margin	4.4%	4.4%	3.8%	4.7%	4.6%	4.0%	4.3%	5.1%	5.2%
Depreciation & Amortization	2.61B	650.00M	580.00M	697.00M	682.00M	674.00M	646.00M	650.00M	738.00M
EPS Basic	23.72	6.30	4.64	7.02	5.76	4.88	5.13	2.65	5.51
EPS Diluted	23.58	6.26	4.64	6.97	5.71	4.85	5.13	2.63	5.45
Shares Outstanding	262.54M	262.54M	265.95M	266.18M	266.18M	280.29M	277.78M	278.46M	281.13M
Diluted Shares Outstanding	264.22M	264.22M	265.95M	268.15M	268.15M	283.22M	277.78M	281.40M	284.05M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	274.95B	247.12B	195.26B	180.52B	174.07B	160.40B	153.57B	48.65B
Cost of Goods Sold	248.97B	221.16B	170.09B	157.02B	151.12B	136.19B	128.49B	32.32B
Gross Profit	25.99B	25.96B	25.18B	23.50B	22.95B	24.21B	25.08B	16.33B
Gross Profit Margin	9.5%	10.5%	12.9%	13.0%	13.2%	15.1%	16.3%	33.6%
Total Operating Expenses	16.86B	16.55B	16.64B	15.05B	15.01B	16.05B	17.00B	12.17B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	14.00B	14.57B	14.32B	13.04B	12.79B	13.66B	13.31B	11.23B
Operating Income (EBIT)	9.13B	9.42B	8.54B	8.45B	7.94B	8.15B	8.08B	4.16B
Operating Margin	3.3%	3.8%	4.4%	4.7%	4.6%	5.1%	5.3%	8.6%
Income Before Tax (EBT)	7.59B	5.27B	5.51B	8.40B	6.79B	10.87B	6.57B	3.58B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	1.38B	1.44B	1.45B	1.23B	1.21B	1.44B	1.68B	498.00M
Other Income/Expense	-1.54B	-4.15B	-3.02B	-53.00M	-1.15B	2.71B	-1.51B	-579.00M
Net Income	5.96B	3.43B	5.16B	6.70B	5.37B	8.46B	5.10B	2.64B
Income Tax Expense	1.34B	1.49B	141.00M	1.61B	1.37B	2.38B	1.45B	935.00M
Net Profit Margin	2.2%	1.4%	2.6%	3.7%	3.1%	5.3%	3.3%	5.4%
EBITDA	11.76B	11.17B	10.35B	10.31B	9.74B	9.96B	10.84B	4.52B
EBITDA Margin	4.3%	4.5%	5.3%	5.7%	5.6%	6.2%	7.1%	9.3%
Depreciation & Amortization	2.63B	1.75B	1.81B	1.86B	1.80B	1.80B	2.77B	356.00M
EPS Basic	22.30	12.25	17.57	21.66	15.89	23.17	13.58	10.69
EPS Diluted	22.17	12.12	17.39	21.41	15.75	22.96	13.44	10.54
Shares Outstanding	265.95M	280.29M	296.88M	313.06M	337.96M	364.98M	375.92M	246.65M
Diluted Shares Outstanding	265.95M	283.22M	296.88M	313.06M	340.97M	368.39M	379.82M	246.65M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.